Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 407

The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.

Global Incidence of Neurological Manifestations Among Patients Hospitalized With COVID-19—A Report for the GCS-NeuroCOVID Consortium and the ENERGY Consortium

Open access
Chou, Sherry H.-Y., Beghi, Ettore, Helbok, Raimund, Moro, Elena, Sampson, Joshua, Altamirano, Valeria, Mainali, Shraddha, Bassetti, Claudio, Suarez, Jose I., McNett, Molly, GCS-NeuroCOVID Consortium and ENERGY Consortium, Nolan, Lawrence, Temro, Kristi, Cervantes-Arslanian, Anna M., Anand, Pria, Mukerji, Shibani, Alabasi, Haitham, Westover, M. Brandon, Kavi, Tapan, John, Sayona, Da Silva, Ivan, Shaik, Arif, Sarwal, Aarti, Izzy, Saef, Liotta, Eric M., Batra, Ayush, Aysenne, Aimee, Rubinos, Clio, Azzam, Ahmed Y., Azab, Mohammed A., Sandall, Justin, Persondek, LeighAnn M., Ulmer, Hanno, Rass, Verena, Pfausler, Bettina, Müller, Christoph, Jung, Simon, Crean, Michael, Meoni, Sara, Bereczki, Daniel, Kovács, Tibor, Agajany, Netta, Armon, Carmel, Wolfson, Sharon, Cotelli, Maria Sofia, Bianchi, Elisa, Riahi, Anis, Öztürk, Serefnur, Ural, Onur, Viktoriia, Gryb, Lesiv, Mariana, Maia, Luis, Oliveira, Vanessa, Seabra, Mafalda, Carvalho, Vanessa, Vespa, Paul, Provencio, Javier, Olson, Daiwai, Hemphill, Claude, Venkatasubba Rao, Chethan P, Ko, Nerissa, Fink, Ericka, Robertson, Courtney, Schober, Michelle, Smith Scott, Ali, Hammond, Michal, Paul, Nicole, Safonova, Aleksandra, Kaplan, Lauren, Ratnayake, Charith, Sharma, Adytia D, Skeel, Abigail, Villamizar Rosales, Carlos, Dolak, Dominika, Varelas, Panayiotis, Lotman, Lev, Kaltenbach, Lalit, David K., Menon·2021·JAMA Network Open

Abstract

Importance: The COVID-19 pandemic continues to affect millions of people globally, with increasing reports of neurological manifestations but limited data on their incidence and associations with outcome. Objective: To determine the neurological phenotypes, incidence, and outcomes among adults hospitalized with COVID-19. Design, Setting, and Participants: This cohort study included patients with clinically diagnosed or laboratory-confirmed COVID-19 at 28 centers, representing 13 countries and 4 continents. The study was performed by the Global Consortium Study of Neurologic Dysfunction in COVID-19 (GCS-NeuroCOVID) from March 1 to September 30, 2020, and the European Academy of Neurology (EAN) Neuro-COVID Registry (ENERGY) from March to October 2020. Three cohorts were included: (1) the GCS-NeuroCOVID all COVID-19 cohort (n = 3055), which included consecutive hospitalized patients with COVID-19 with and without neurological manifestations; (2) the GCS-NeuroCOVID COVID-19 neurological cohort (n = 475), which comprised consecutive patients hospitalized with COVID-19 who had confirmed neurological manifestations; and (3) the ENERGY cohort (n = 214), which included patients with COVID-19 who received formal neurological consultation. Exposures: Clinically diagnosed or laboratory-confirmed COVID-19. Main Outcomes and Measures: Neurological phenotypes were classified as self-reported symptoms or neurological signs and/or syndromes assessed by clinical evaluation. Composite incidence was reported for groups with at least 1 neurological manifestation. The main outcome measure was in-hospital mortality. Results: Of the 3055 patients in the all COVID-19 cohort, 1742 (57%) were men, and the mean age was 59.9 years (95% CI, 59.3-60.6 years). Of the 475 patients in the COVID-19 neurological cohort, 262 (55%) were men, and the mean age was 62.6 years (95% CI, 61.1-64.1 years). Of the 214 patients in the ENERGY cohort, 133 (62%) were men, and the mean age was 67 years (95% CI, 52-78 years). A total of 3083 of 3743 patients (82%) across cohorts had any neurological manifestation (self-reported neurological symptoms and/or clinically captured neurological sign and/or syndrome). The most common self-reported symptoms included headache (1385 of 3732 patients [37%]) and anosmia or ageusia (977 of 3700 patients [26%]). The most prevalent neurological signs and/or syndromes were acute encephalopathy (1845 of 3740 patients [49%]), coma (649 of 3737 patients [17%]), and stroke (222 of 3737 patients [6%]), while meningitis and/or encephalitis were rare (19 of 3741 patients [0.5%]). Presence of clinically captured neurologic signs and/or syndromes was associated with increased risk of in-hospital death (adjusted odds ratio [aOR], 5.99; 95% CI, 4.33-8.28) after adjusting for study site, age, sex, race, and ethnicity. Presence of preexisting neurological disorders (aOR, 2.23; 95% CI, 1.80-2.75) was associated with increased risk of developing neurological signs and/or syndromes with COVID-19. Conclusions and Relevance: In this multicohort study, neurological manifestations were prevalent among patients hospitalized with COVID-19 and were associated with higher in-hospital mortality. Preexisting neurological disorders were associated with increased risk of developing neurological signs and/or syndromes in COVID-19.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1001/jamanetworkopen.2021.12131

Cites

44 of 44 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 44 references

Cited by

See all 407

Metadata

Authors
Chou, S. H.-Y., Beghi, E., Helbok, R., Moro, E., Sampson, J., Altamirano, V., Mainali, S., Bassetti, C., Suarez, J. I., McNett, M., GCS-NeuroCOVID Consortium and ENERGY Consortium, Nolan, L., Temro, K., Cervantes-Arslanian, A. M., Anand, P., Mukerji, S., Alabasi, H., Westover, M. B., Kavi, T., John, S., Da Silva, I., Shaik, A., Sarwal, A., Izzy, S., Liotta, E. M., Batra, A., Aysenne, A., Rubinos, C., Azzam, A. Y., Azab, M. A., Sandall, J., Persondek, L. M., Ulmer, H., Rass, V., Pfausler, B., Müller, C., Jung, S., Crean, M., Meoni, S., Bereczki, D., Kovács, T., Agajany, N., Armon, C., Wolfson, S., Cotelli, M. S., Bianchi, E., Riahi, A., Öztürk, S., Ural, O., Viktoriia, G., Lesiv, M., Maia, L., Oliveira, V., Seabra, M., Carvalho, V., Vespa, P., Provencio, J., Olson, D., Hemphill, C., Venkatasubba Rao, C. P., Ko, N., Fink, E., Robertson, C., Schober, M., Smith Scott, A., Hammond, M., Paul, N., Safonova, A., Kaplan, L., Ratnayake, C., Sharma, A. D., Skeel, A., Villamizar Rosales, C., Dolak, D., Varelas, P., Lotman, L., Kaltenbach, L., & David K., M.
Venue
JAMA Network Open
Published
2021-05-11
Volume
4
Issue
5
Pages
e2112131
ISSN
2574-3805 (ISSN-L)
OpenAlex
W3161773261
Cited by
407
References
44
FWCI
35.96
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Global Incidence of Neurological Manifestations Among Patients Hospitalized With COVID-19—A Report for the GCS-NeuroCOVID Consortium and the ENERGY Consortium. https://app.cochat.ai/papers/10.1001/jamanetworkopen.2021.12131
The paper
Chou, S. H.-Y., Beghi, E., Helbok, R., Moro, E., Sampson, J., Altamirano, V., Mainali, S., Bassetti, C., Suarez, J. I., McNett, M., GCS-NeuroCOVID Consortium and ENERGY Consortium, Nolan, L., Temro, K., Cervantes-Arslanian, A. M., Anand, P., Mukerji, S., Alabasi, H., Westover, M. B., Kavi, T., . . . David K., M. (2021). Global Incidence of Neurological Manifestations Among Patients Hospitalized With COVID-19—A Report for the GCS-NeuroCOVID Consortium and the ENERGY Consortium. JAMA Network Open. https://doi.org/10.1001/jamanetworkopen.2021.12131

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.